AKT1 and cancer: Studies have shown that the activation of PI3K and Akt can trigger and accelerate the transformation and proliferation of skin epithelial cells, while the use of inhibitors can inhibit the proliferation of cancer cells and improve the level of programmed cell death [44, 45].